Diagnosis
When diagnosing a thymoma, the doctor will first conduct a physical examination. Following this, various imaging tests will be conducted to obtain detailed information about the size and activity of the tumor. A CT scan is performed to generate a 3D image of the organs and tissues, while an MRI provides more detailed images. Additionally, a PET scan with a radioactive sugar injection helps identify which cells are more active than others.
Once these initial tests are completed, a pathologist may perform a biopsy. In some cases, a Chamberlain procedure is also carried out. This procedure involves inserting a tube through an incision next to the breastbone to obtain lymph node samples. After the necessary tests and procedures, the tumor is then staged.
Masaoka-Koga Staging: A Reliable Indicator of Thymoma Malignancy
The Masaoka-Koga staging system, initially developed by Akira Masaoka in 1981 and later updated by Kenji Koga in 1994, is widely recognized as the most reliable method for assessing the malignancy of thymoma. This staging system offers valuable insights into the extent of tumor spread and its impact on surrounding tissues and organs.
Stage 1 of the Masaoka-Koga staging system indicates that the thymoma is completely encapsulated within the thymus. In other words, the tumor is confined to its place of origin and has not spread beyond the thymic tissue.
Stages IIA and IIB signify varying degrees of microscopic or macroscopic spread of the thymoma to the fatty tissue within the thoracic cavity. These stages suggest that the tumor has started to infiltrate the surrounding area but has not yet reached other organs or structures.
When the thymoma progresses to Stage III, it has extended its reach beyond the thoracic cavity and has invaded the lungs, pericardium (the sac around the heart), and neighboring organs. At this point, the tumor’s presence becomes more pronounced and poses a greater threat to the patient’s health.
Stages IVA and IVB indicate the most advanced form of thymoma, characterized by metastasis. In Stage IVA, the tumor has spread to the outer membranes of the lungs, pleura (the lining of the lung cavity), and heart. In Stage IVB, metastasis involves the blood and lymph nodes, indicating a more aggressive and widespread disease.
The Masaoka-Koga staging system provides clinicians with crucial information about the stage of thymoma and its potential for malignancy, aiding in treatment planning and prognosis assessment.